JP Morgan Chase’s Ingevity NGVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.15M | Buy |
117,159
+39,461
| +51% | +$2.7M | ﹤0.01% | 2868 |
|
|
2025
Q4 | $4.6M | Sell |
77,698
-48,382
| -38% | -$2.63M | ﹤0.01% | 3388 |
|
|
2025
Q3 | $6.96M | Buy |
126,080
+50,498
| +67% | +$2.63M | ﹤0.01% | 3066 |
|
|
2025
Q2 | $3.26M | Sell |
75,582
-4,030
| -5% | -$155K | ﹤0.01% | 3535 |
|
|
2025
Q1 | $3.15M | Sell |
79,612
-106,644
| -57% | -$4.72M | ﹤0.01% | 3534 |
|
|
2024
Q4 | $7.59M | Buy |
186,256
+68,675
| +58% | +$2.86M | ﹤0.01% | 2967 |
|
|
2024
Q3 | $4.59M | Buy |
117,581
+23,460
| +25% | +$934K | ﹤0.01% | 3281 |
|
|
2024
Q2 | $4.11M | Sell |
94,121
-137,814
| -59% | -$6.66M | ﹤0.01% | 3185 |
|
|
2024
Q1 | $11.1M | Buy |
231,935
+95,087
| +69% | +$4.27M | ﹤0.01% | 2385 |
|
|
2023
Q4 | $6.46M | Sell |
136,848
-18,011
| -12% | -$748K | ﹤0.01% | 2859 |
|
|
2023
Q3 | $7.37M | Sell |
154,859
-28,811
| -16% | -$1.57M | ﹤0.01% | 2530 |
|
|
2023
Q2 | $10.7M | Sell |
183,670
-35,091
| -16% | -$2.1M | ﹤0.01% | 2238 |
|
|
2023
Q1 | $15.6M | Buy |
218,761
+2,889
| +1% | +$229K | ﹤0.01% | 1868 |
|
|
2022
Q4 | $15.2M | Buy |
215,872
+5,342
| +3% | +$377K | ﹤0.01% | 1881 |
|
|
2022
Q3 | $12.8M | Sell |
210,530
-5,999
| -3% | -$402K | ﹤0.01% | 1963 |
|
|
2022
Q2 | $13.7M | Sell |
216,529
-648
| -0.3% | -$42.2K | ﹤0.01% | 1918 |
|
|
2022
Q1 | $13.9M | Sell |
217,177
-43,498
| -17% | -$2.91M | ﹤0.01% | 2069 |
|
|
2021
Q4 | $18.7M | Buy |
260,675
+24,875
| +11% | +$1.89M | ﹤0.01% | 1885 |
|
|
2021
Q3 | $16.8M | Sell |
235,800
-4,684
| -2% | -$369K | ﹤0.01% | 1905 |
|
|
2021
Q2 | $19.6M | Sell |
240,484
-38,613
| -14% | -$3.11M | ﹤0.01% | 1866 |
|
|
2021
Q1 | $21.1M | Buy |
279,097
+32,320
| +13% | +$2.35M | ﹤0.01% | 1725 |
|
|
2020
Q4 | $18.7M | Buy |
246,777
+132,061
| +115% | +$8.6M | ﹤0.01% | 1672 |
|
|
2020
Q3 | $5.68M | Buy |
114,716
+35,002
| +44% | +$1.98M | ﹤0.01% | 2463 |
|
|
2020
Q2 | $4.19M | Buy |
79,714
+20,418
| +34% | +$969K | ﹤0.01% | 2591 |
|
|
2020
Q1 | $2.09M | Sell |
59,296
-102,325
| -63% | -$5.98M | ﹤0.01% | 2938 |
|
|
2019
Q4 | $14.1M | Buy |
161,621
+10,250
| +7% | +$896K | ﹤0.01% | 1837 |
|
|
2019
Q3 | $12.8M | Buy |
151,371
+90,181
| +147% | +$8.03M | ﹤0.01% | 1937 |
|
|
2019
Q2 | $6.14M | Sell |
61,190
-52,547
| -46% | -$5.28M | ﹤0.01% | 2478 |
|
|
2019
Q1 | $12M | Buy |
113,737
+64,821
| +133% | +$6.51M | ﹤0.01% | 1891 |
|
|
2018
Q4 | $4.09M | Sell |
48,916
-12,097
| -20% | -$1.1M | ﹤0.01% | 2736 |
|
|
2018
Q3 | $6.22M | Sell |
61,013
-55,884
| -48% | -$5.39M | ﹤0.01% | 2571 |
|
|
2018
Q2 | $9.45M | Sell |
116,897
-30,766
| -21% | -$2.45M | ﹤0.01% | 2190 |
|
|
2018
Q1 | $10.9M | Sell |
147,663
-15,505
| -10% | -$1.16M | ﹤0.01% | 1968 |
|
|
2017
Q4 | $11.5M | Buy |
163,168
+41,564
| +34% | +$3M | ﹤0.01% | 2011 |
|
|
2017
Q3 | $7.6M | Buy |
121,604
+16,052
| +15% | +$951K | ﹤0.01% | 2213 |
|
|
2017
Q2 | $6.06M | Sell |
105,552
-64,301
| -38% | -$3.78M | ﹤0.01% | 2350 |
|
|
2017
Q1 | $10.3M | Sell |
169,853
-42,205
| -20% | -$2.39M | ﹤0.01% | 1915 |
|
|
2016
Q4 | $11.6M | Buy |
212,058
+114,819
| +118% | +$5.51M | ﹤0.01% | 1819 |
|
|
2016
Q3 | $4.48M | Buy |
97,239
+39,590
| +69% | +$1.67M | ﹤0.01% | 2327 |
|
|
2016
Q2 | $1.96M | Buy |
+57,649
| New | +$1.8M | ﹤0.01% | 2815 |
|
Other funds holding NGVT
VPM
VCM
SBH
SCM
JP Morgan Chase's NGVT Position: Q1 2026 in Review
JP Morgan Chase increased its Ingevity (NGVT) stake by 51% in Q1 2026, buying an estimated $2.7M and bringing the position to 117,159 shares worth $8.15M. The position accounts for ﹤0.01% of the portfolio, ranked #2868.
JP Morgan Chase first reported a position in NGVT in Q2 2016 and has held it in 40 quarters since. The position peaked at $21.1M in Q1 2021. 307 funds tracked by Wall St. Rank hold NGVT as of Q1 2026.
- JP Morgan Chase held 117,159 shares of Ingevity worth $8.15M as of Q1 2026.
- JP Morgan Chase bought 39,461 Ingevity shares in Q1 2026, an estimated $2.7M.
- Ingevity made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #2868 holding.
- JP Morgan Chase first reported a position in Ingevity in Q2 2016 and has held it in 40 quarters since.
- JP Morgan Chase's Ingevity position peaked at $21.1M in Q1 2021.
- 307 funds tracked by Wall St. Rank held Ingevity as of Q1 2026.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.